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Rapid development and commercialization of new products is of vital importance for small 
and medium sized enterprises (SME) in regulated sectors. Due to strict regulations, competi-
tive advantage can hardly be achieved through the effectiveness of product concepts only. If 
an SME in a highly regulated sector wants to excell in new product development (NPD) per-
formance, the company should focus on the flexibility, speed, and productivity of its NPD 
function: i.e. the development process effectiveness. Our main research goals are first to ex-
plore if SMEs should focus on their their development process effectiveness rather than on 
their product concept effectiveness to achieve high NPD performance; and second, to explore 
whether a shared pattern in the organization of the NPD function can be recognized to affect 
NPD performance positively. The medical devices sector in Spain is used as an example of a 
highly regulated sector. A structured survey among 11 SMEs, of which 2 were studied also as 
in in-depth case studies, led to the following results. First of all, indeed the companies in the 
dataset which focused on the effectiveness of their development process, stood out in NPD 
performance. Further, the higher performing companies did have a number of commonal-
ities in the organisation of their NPD function:   
1) The majority of the higher performing firms had an NPD strategy characterized by a 
predominantly incremental project portfolio. 
2) a) Successful firms with an incremental project portfolio combined this with a functional 
team structure  
b) Successful firms with a radical project portfolio combined this with a heavyweight or 
autonomous team structure. 
3) A negative reciprocal relationship exists between formalization of the NPD processes 
and the climate of the NPD function, in that a formalized NPD process and an innovative 
climate do not seem to reinforce each other. Innovative climate combined with an in-
formal NPD process does however contribute positively to NPD performance. This effect 
was stronger in combination with a radical project portfolio. 
The highest NPD performance was measured for companies focusing mainly on incremental 
innovation. It is argued that in highly regulated sectors, companies with an incremental 
product portfolio would benefit from employing a functional structure. Those companies 
who choose for a  more radical project portfolio in highly regulated sectors should be aware 
that they are likely to excell only in the longer term by focusing on strategic flexibility. In 
their NPD organization, they might be well advised to combine informal innovation 
processes with an innovative climate.  
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Introduction 
Innovation is a key driver of sustainable competitive advantage and one of the key challenges for 
small- and medium sized companies (O'Regan et al. 2006). Therefore, SMEs need to remain active 
in new product development (NPD). It is difficult for small-and medium sized companies (SMEs)1 in 
regulated sectors to development new products, because heavy regulatory involvement imposes a 
number of difficulties on the NPD process. Products have to meet these strict regulations in terms 
of quality, safety, functionality, and manufacturability, which makes it difficult for SMEs to differen-
tiate in terms of the effectiveness of the product concepts. However, there are big differences in the 
NPD performance of SMEs. Then, the questions are 1) how do SMEs in regulated sectors distinguish 
themselves in terms of innovation performance and 2) how can SMEs in regulated sectors be suc-
cessful in new product development. 
In this research, the Spanish medical devices sector is used as an illustration of a highly regulated 
sector. The medical devices development process is characterized by a heavy regulatory involve-
ment. (Shaw 1998). Companies in the medical devices sector are experiencing a need to develop 
new products more rapidly to satisfy expanding and changing customer requirements in light of 
new technologies and intensifying global competition (Millson and Wilemon 2000). The ability of 
organizations in the medical devices sector to develop and commercialize new products fast is a 
major competitive advantage (Atun et al. 2002), as speed is an important driver for new product 
development (NPD) performance (Calantone and Di Benedetto 2002; Langerak and Hultink 2005; 
Lynn et al. 1999; Takayama et al. 2002).  
It is important to realize that in highly regulated sectors, such as the medical development sector, 
the product concept effectiveness of all acting companies almost per definition will be high, and va-
riance in this performance measure will be low. This is so because all (new) product (concepts) 
have to comply with the same strict regulations. In this type of sectors, and especially for the SMEs 
in it, the effectiveness of the NPD process effectiveness stands a much better chance to make a dif-
ference. The development process effectiveness represent a measurement of the current NPD per-
formance beyond the requirements imposed by regulations of the sector. This means that it is to be 
expected that the SMEs we looked at in the Spanish medical devices sector would try to achieve 
competitive advantage in terms of speed, productivity and flexibility of their product development 
process, rather than in terms of manufacturability, functionality and cost of the product concept, 
which would be comparable for all players in the field.  
 
According to DeWeerd-Nederhof et al (2008) both the current and future NPD performance are 
heavily influenced by the way the NPD function is organized (i.e. the NPD configuration). The or-
ganization of the NPD function consists of the strategy, structure, climate and process of the NPD 
function (DeWeerd-Nederhof et al. 2007; DeWeerd-Nederhof et al. 2008). Building on this, and in 
light of the peculiarities faced by SMEs in highly regulated sectors, we set out to search for a shared 
pattern in the organization of the NPD function of Spanish SMEs in the medical devices sector, 
which can be related to high NPD process effectiveness, and ultimately to outperforming competi-
tors. 
 
Thus, our main research goals are first to explore differences in product concept effectiveness 
and development process effectiveness among SMEs in the Spanish medical devices sector, to see 
whether or not the current NPD performance would indeed be mainly influenced by the develop-
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ment process effectiveness; and second, to explore whether a shared pattern in the organization of 
the NPD function  can be recognized to affect current  NPD performance positively.  
 
In the next section we first provide the theoretical framework on both the current NPD perform-
ance, and the variables that are included in the organizational configuration of the NPD function 
(NPD strategy, structure, climate, and process (DeWeerd-Nederhof et al. 2007)). Next we provide 
the research design and methodology. We then present the research results based on a structured 
survey among 11 SMEs in the Spanish medical devices sector. The results are further illustrated by 
two real-life case descriptions. In the discussion and conclusion results are further elaborated and 
managerial implications are explicitly addressed. 
 
Theoretical Framework 
 
NPD performance 
The NPD performance consists of the product concept effectiveness on the one hand, and the devel-
opment process effectiveness on the other hand. The product concept effectiveness is used to de-
fine how well a new product concept fits with internal and external characteristics of the company. 
Whereas the development process effectiveness concept is used to define how effective the devel-
opment process is executed (Brown and Eisenhardt 1995). Figure 1 shows a schematic overview of 
the different constructs that together build NPD performance.  
The NPD performance is a dynamic concept that has both a short-term and a long-term component. 
The short term component is the Operational Effectiveness and refers to the effectiveness 
of today’s work, whereas the long term component is the Strategic Flexibility which relates to the 
readiness to adapt to, anticipate or even create future NPD performance requirements (DeWeerd-
Nederhof et al. 2008). For this research the focus is on operational effectiveness as the aim is to 
measure the current NPD performance.  
 
 
Figure 1: Schematic overview of the constructs that together build NPD performance. 
 
Pettigrew and Whipp (1991) studied organizational change and differences in NPD performance 
similarly using a content-context-process framework. Content represents the objectives, purpose, 
and goals of the organization (Pettigrew and Whipp 1991). Context represents the environment of 
the company, and process represents the product development process of the organization. The 
content and context dimensions of Pettigrew and Whipp (1991) can be linked to the product con-
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cept effectiveness of Brown and Eisenhardt (1995), whereas the process that Pettigrew and Whipp 
(1991) describe is similar to the development process effectiveness that Brown and Eisenhardt 
(1995) describe. 
Strict regulations are a unique characteristic of the medical devices sector, and this heavy regula-
tory involvement characterizes the medical devices development process (Shaw 1998). The prod-
uct concept effectiveness is highly tied to this regulatory process, which makes it difficult for com-
panies to differentiate in terms of this dimension. Also, Pettigrew and Whipp (1991) suggest that 
companies that operate in the same sector (like in the medical devices sector) share environmental 
characteristics such as regulations, dynamism, and fragmentation of the sector. The medical devices 
sector is similar to other industries in that SMEs dominate the sector. Medical devices companies 
often don’t compete on price but rather seek to deliver products with a good quality/price-ratio. 
However, the processes these companies use to achieve their goals and develop new medical de-
vices do differ as does the organization of the NPD function of these companies. 
The current NPD performance of SMEs in the medical devices sector varies greatly. Since the 
product concept effectiveness is heavily influenced by the set regulations, we hypothesize that 
SMEs in the medical devices sector emphasize on development process effectiveness rather than on 
product concept effectiveness to achieve high NPD performance. Takeuchi and Nonaka (1986) 
point this out by stating that the higher the speed with which changes occur and the more the com-
petence in the field of NPD grows, the more firms must focus their processes on speed and flexibil-
ity (Takeuchi and Nonaka 1986). Furthermore the framework of Pettigrew and Whipp (1991) indi-
cates that the content and context of companies in the medical devices sector does not differ, and 
that they can only distinguish themselves in terms of the process. This supports our previous as-
sumption that companies can distinguish themselves more by focusing on development process 
effectiveness rather than through product concept effectiveness, and leads to the investigation of 
our proposition: 
 
Proposition 1: SMEs in the medical devices sector focus on their development process effec-
tiveness rather than on their product concept effectiveness to achieve high NPD performance. 
 
Our study is focussing on the importance of development process effectiveness as part of the cur-
rent NPD performance. The NPD performance is influenced by the way the NPD function is organ-
ized, also called the NPD configuration. Contributing to sustained competitive advantage requires a 
fit of the NPD configuration with the NPD system and between the NPD system and its context 
(DeWeerd-Nederhof et al. 2007). The way the NPD function is organized affects both the develop-
ment process effectiveness, and (to a lesser extent as we proposed) the product concept effective-
ness. Differences in development process effectiveness therefore might be explained by the differ-
ence in NPD configuration. This leads to the second proposition. 
 
Proposition 2: SMEs in the medical devices sector that achieve high development process ef-
fectiveness share a pattern in the organization of their NPD function. 
 
We utilize the concepts of NPD strategy, NPD structure, and NPD climate to further specify the or-
ganization of the NPD function (DeWeerd-Nederhof et al. 2007). These concepts are further ex-
plained in the following subsections. 
 
NPD Strategy 
The NPD strategy of a firm can be defined as: “the aggregate pattern of product introductions that 
emerge from the firm over time” (Firth and Narayanan 1996). The purpose of the new product 
strategy is to link the products to the overall objectives of the firm and to assist in the search for 
 5
new products (Firth and Narayanan 1996). SMEs with a clear strategy perform better than SMEs 
that lack a clear strategy (Kargar and Parnell 1996; O'Regan et al. 2006). Clark and Wheelwright 
(1993) identify three orientations of the strategy; the technology strategy, the product strategy, and 
the market strategy. The technology strategy refers to the acquiring, developing, and applying of 
technology for competitive advantage. The product strategy should contain a clear plan for the de-
velopment of future products. Finally the market strategy should focus on the question what the 
target customers will be (Clark and Wheelwright 1993). 
Gatignon and Xuereb (1997) propose a similar typology of strategic orientation (technology ori-
entation, competitive orientation, and customer orientation), and link this to the demand uncer-
tainty in the market. In the medical devices sector the hospital budgets heavily influence the buying 
behaviour of the customers. This buying behaviour is also strongly influenced by informal commu-
nication between buyers. This causes demand uncertainty in the medical devices sector (Biemans 
1989). When demand uncertainty is high the strategic orientation should be a customer orientation 
(Gatignon and Xuereb 1997). In the field of NPD in Spanish firms, Varela and Benito (2005) find 
that firms that are market oriented get better NPD results than those that do not use this strategic 
orientation (Varela and Benito 2005).  
Next to the strategic orientation, the project portfolio is an important part of the NPD strategy 
(Wheelwright and Clark 1992). Wheelwright and Clark (1992) view NPD strategy as the project 
portfolio of an organization. It must be clear which type projects are present in the organization. 
Wheelwright and Clark (1992) distinguish between incremental projects (derivative projects), 
radical projects (breakthrough projects), and platform projects (between incremental and radical 
projects) (Gatignon et al. 2002; Wheelwright and Clark 1992). Incremental innovation projects 
range from cost-reduced versions of existing products to add-ons or enhancements for and existing 
production process (Wheelwright and Clark 1992). Radical innovation projects involve significant 
changes to existing products and processes. It involves the development or application of signifi-
cant new technologies or products to markets that are either non-existent or require dramatic be-
haviour changes to existing markets (Feller et al. 2006; Wheelwright and Clark 1992). 
 
NPD Climate 
The second aspect of the organization of the NPD function is the NPD climate. The climate is re-
garded as a conglomerate of attitudes, feelings, and behaviours which characterizes life in the or-
ganization, and exists independently of the perceptions and understandings of the members of the 
organization (Ekvall 1996). In order to operationalize climate we use the 10 climate dimensions of 
Ekvall (1996) that stimulate the NPD performance. Cabra (1996) found problems with the chal-
lenge dimension by conducting factor analysis with North American samples.  Further work by 
Isaksen, Lauer, and Ekvall (1998) and later Isaksen and Lauer (2002) found that the dynamism di-
mension was not discriminating. In this research we use the dimensions proposed by Ekvall (1996), 
excluding the dynamism dimension. In this research, a climate that stimulates innovation (innova-
tive climate) is a climate with high levels of “challenge, freedom, idea support, trust, playfulness, 
debates, risk taking, and idea time” and a low level of conflicts. 
 
NPD Structure 
The third concept of the organization of the NPD function is the structure of the NPD function. This 
structure refers broadly to the structure of project teams and the way the people in the NPD func-
tion are organized. This work is based on efforts of (Clark and Wheelwright 1992) who showed that 
effective product and process development requires teams that integrate people with multiple spe-
cialized capabilities. These teams are also referred to as cross-functional product development 
teams. Cross- functional development teams have become increasingly important due to complexi-
ties in the pace, diffusion and the use of multiple technologies to solve customer problems (Walsh 
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and Linton 2001) as well as burgeoning global competition (McDonough III 2000). This is also in 
line with the research of Sosa et al (2004) who state that complex product development requires 
structuring the organization into groups of cross-functional design teams to design systems and 
components (Sosa et al. 2004), and with the research of Cooper et al (2004a) who have identified 
the presence of cross-functional teams as a common fact in organizations they rated as best per-
formers (Cooper et al. 2004a) 
Clark and Wheelwright (1992) have characterized a number of structures for project teams. It 
depends on the environment, organization size, and innovation type which project structure is best 
suitable (Clark and Wheelwright 1992). They distinguish between the functional, lightweight, 
heavyweight, and autonomous team structure. The team structure that is used by the company 
needs to fit in the context. For new product development in the medical devices sector it is very 
important that all functional areas are involved in the development of a new product, because of the 
rapid changes in technology and competition. However it should be prevented that a project team 
gets carried away by its own ideas and fails to meet regulations, or that senior management looses 
the control over the team (which is likely to occur in the autonomous team structure). Therefore we 
expect that the heavyweight team structure is likely to be the most successful in the context of the 
medical devices sector. Also the success factors for cross-functional teams (McDonough III 2000) 
can be found most clearly in the characteristics of the heavyweight team structure.  
Another aspect of the NPD structure is the formalization of the development process (Griffin and 
Page 1993). Formalisation refers to the degree in which the process is subject to rules, procedures 
and structures previously specified (Johne 1984). Walsh and Dewar (1987) link the degree of for-
malization with the organizational life cycle. They state that the more mature the organization, the 
more formalized the processes are (Walsh and Dewar 1987). For new product development, it is 
stated that companies with a formal development process are more successful in the commerciali-
sation of new products (Booz and Hamilton 1982). 
 
We investigate both propositions based on the above literature. The next section describes the 
methodology we follow to 1) investigate if SMEs in the Spanish medical devices sector should focus 
on development process effectiveness to achieve high innovation performance, 2) explore if there is 
a pattern in the organization of the NPD function that these companies share and 3) what this or-
ganization of the NPD function looks like. 
 
Methodology 
We utilize a case based method as described by Yin (Yin 2003) and Eisenhardt (Eisenhardt 1989). 
We leveraged the international Patterns in NPD project. This project is aimed at developing knowl-
edge in the new product development area, by describing, exploring and analysing the organisation 
of the innovation journey. We focus on the population of Spanish SMEs in the medical devices sec-
tor.  
 
Sampling Process 
Consistent with the case study method, we gathered data of a full population in one specific sector, 
to reduce extraneous variation (Eisenhardt 1989). Data was gathered in the Spanish medical de-
vices and disposables sector. The medical devices sector is the focus of this research because (1) 
differences in innovation performance of the companies depend (due to strict regulations) on man-
agement issues, and not on environmental or product concept issues, and (2) innovative capability 
is in this sector of vital importance (Atun et al. 2002). Data gathering took place in the spring of 
2006. 
Leveraging the DUNS database we used the Spanish SIC codes (CNAE) 33100 and 33200 to iden-
tify a number of organizations. A total of 109 companies were selected. These companies were first 
 7
screened on origin and number of employees. The companies with CNAE 33200 were also screened 
on the fact whether they were active in the medical devices sector or not. Companies with other 
origins than Spanish, organizations with a total number of employees of 5 or less, and organizations 
(with CNAE 33200) not active in the medical devices sector were deleted from the list. 57 Compa-
nies remained and were contacted to find out whether they had an NPD function. From this 35 
companies remained, of which 31 companies were interested to participate in the study.  
 
Data Description 
To the NPD managers of the 31 companies that were interested to participate a questionnaire about 
the organization and performance of the NPD function was sent. This questionnaire was developed 
as part of the international ‘Patterns in NPD project’. We ended up with 12 filled-in questionnaires 
from companies in the Spanish medical devices sector, which results in a response rate of 34,29%. 
One of the cases was deleted from the sample, as the number of FTE of the particular company 
was 650 FTE whereas the focus of this research is on small – and medium sized companies (FTE ≤ 
250). This resulted in a dataset of N=11 companies, with which the propositions were further ex-
plored. Table 1 gives general information about the companies in the dataset. 
 
Table 1: General information of the companies in the dataset 
 
 
Case# 
FTE Products Profit Sales Profit/FTE Sales/FTE 
1 12 Interventional cardiology products € 113.004,31 € 4.000.000,00 € 9.417,03 € 333.333,33 
2 120 
Products based in three main lines: 
Infusion, Respiratory and Bandages 
€1.064.975,42 €10.000.000,00 € 8.874,80 € 83.333,33 
3 35 
Solariums, professional equipment of 
aesthetic and aesthetic medicine 
€ 124.263,70 € 7.000.000,00 € 3.550,39 € 200.000,00 
4 80 
Four product groups: measuring, quali-
ty & metering, industrial electric pro-
tection, and power factor protection 
€5.334.493,30 €80.000.000,00 € 66.681,17 
€ 
1.000.000,00 
5 36 Prostheses and implants € 260.478,55 € 5.000.000,00 € 7.235,52 € 138.888,89 
6 32 
Female protection slips, female hygie-
nic bandages, and children’s diapers 
€ 44.271,19 € 3.200.000,00 € 1.383,47 € 100.000,00 
7 12 Orthopedic elastic products € 64.910,78 €4.000.000,00 € 5.409,23 € 333.333,33 
8 167 
Medical disposables for neurosurgery 
and endosurgery 
 €54.000.000,00 €   - € 323.353,29 
9 80 
Wide range of single use and reusable 
lab ware for chemical, clinical, research 
and industrial testing laboratories, 
swabs for sample collection and trans-
port of microbiological material, sam-
pling containers, blood collection 
tubes, test tubes 
€ 72.800,98 €18.000.000,00 € 910,01 € 225.000,00 
10 49 Dental equipment and optical units € 683.275,34 € 9.600.000,00 € 13.944,39 € 195.918,37 
11 60 Laboratory equipment € 765.986,92 €18.000.000,00 € 12.766,45 € 300.000,00 
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Measurements 
NPD performance is a dynamic concept. It is divided in the current NPD performance (operational 
effectiveness) which refers to the effectiveness of today’s work, and the future NPD performance 
(strategic flexibility) which relates to the readiness to adapt to, anticipate or even create future re-
quirements (see also Figure 1) (Brown and Eisenhardt 1995; DeWeerd-Nederhof et al. 2005). This 
research focuses on the current NPD performance, which consists of the development process effec-
tiveness, and the product concept effectiveness. Table 2 shows the constructs and items that to-
gether form the product concept effectiveness and the development process effectiveness. Table 2 
also shows the reliability of the constructs and the literature that was used to build the constructs. 
All items are measurement on a 7-point Likert scale, ranging from ‘1 = Not at all achieved’ to ‘7 = 
Very well achieved’. 
 
Table 2: Overview and reliability statistics of the performance scale 
 
 Current NPD performance 
 Product concept effectiveness (pce) Development process effectiveness (NPDpe) 
Construct 
Fit with market de-
mands 
Fit with firm compe-
tences 
Speed Flexibility Productivity 
N of Items 6 6 6 6 6 
Measure-
ment scale 
7-point Likert  
scale 
7-point Likert  
scale 
7-point Likert  
scale 
7-point Likert 
scale 
7-point Likert 
scale 
Cronbach’s 
Alpha 
α = 0,788 α = 0,747 α = 0,893 α = 0,645 α = 0,778 
Based on Customer satisfac-
tion, timeliness, 
product price, quali-
ty (Chiesa et al. 
1996) 
Sales and profit im-
pact (Bretani and 
Kleinschmidt 2004) 
R&D/Manufacturing 
integration (Swink 
1999; Yam et al. 
2004) 
R&D/Marketing inte-
gration (Leenders and 
Wierenga 2002) 
Speed relative to 
schedule (Kessler 
and Bierly 2002) 
Development time 
(DT), concept to 
customer time 
(CTC), total time 
(TT) (Griffin 1997) 
Speed and com-
mitment of the 
NPD decision-
making process, 
(Griffin and Page 
1993) 
Average time 
and cost of 
redesign, en-
hancement 
(Chiesa et al. 
1996; Thomke 
1997) 
The ability to 
change specs 
late (Thomke 
1997) 
The possibility 
for lower devel-
opment budget 
(Iansiti 1993) 
Cost relative to 
budget, competi-
tors (Kessler and 
Bierly 2002) 
Engineering 
hours, cost of 
materials, cost of 
tooling (Clark 
and Wheelwright 
1993) 
 
Current NPD performance is measured by using all the scales of the product concept effectiveness 
and development process effectiveness. Product concept effectiveness is measured as the average 
score of the constructs ‘fit with market demands’ and ‘fit with firm competences’. Development 
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process effectiveness is measured as the average of the constructs ‘speed’, ‘flexibility’, and ‘produc-
tivity’. 
We use the development process effectiveness to determine whether a company is high or low 
performing. If the development process effectiveness of the company is higher or equals the aver-
age development process effectiveness of the dataset (which is 4,5), then the company is ‘high per-
forming’. Else the company is ‘low performing’. Table 3 shows the scores on product concept effec-
tiveness, and development process effectiveness of the companies in the dataset. Table 3 also 
shows whether the companies are high or low performing based on the above described method. 
 
Table 3: Performance scores of the companies in the dataset 
Case # Product concept 
effectiveness 
Development process 
effectiveness 
High/ Low 
performing 
1 5,9 2,5 Low 
2 4,3 4,0 Low 
3 4,0 4,1 Low 
4 5,3 4,7 High 
5 4,3 3,3 Low 
6 4,8 4,5 High 
7 5,3 5,3 High 
8 6,4 5,1 High 
9 5,7 4,9 High 
10 6,1 5,9 High 
11 4,8 4,7 High 
Average 5,2 4,5  
 
 
The NPD climate was measured by asking the respondents to indicate on a 7-point Likert scale to 
what extent employees have the freedom to define their own work and to what extent there is time 
for people to develop unplanned new ideas (Pullen et al. 2009). This measurement of NPD climate 
is based on work by Isaksen and Lauer (2002), and Ekvall (1996), who developed nine items to 
measure activities related to the climate of the respondents’ NPD function. A climate that stimulates 
innovation is a climate with high levels of “challenge, freedom, idea support, trust, playfulness, de-
bates, risk taking, and idea time” (Ekvall 1996) 
To measure the variable NPD structure, the team structure types of Clark and Wheelwright 
(1992) were used. In the survey, respondents were asked to indicate whether they use a functional, 
lightweight, heavyweight or autonomous team structure (Pullen et al. 2009). 
The level of formalization and presence of cross-functional teams was measured by presenting 
multiple descriptions of development processes of a business unit. Based on descriptions of the 
NPD system by Griffin and Page (1993), the respondents were asked to indicate which development 
process most closely describes the development process that is used in their business unit (Pullen 
et al. 2009). 
The strategic orientation was measured with a seven-point Likert scale ranging from ‘1 = strongly 
disagree’ to ‘7 = strongly agree’. Respondents were asked to indicate the level of agreement with 
statements considering the technology strategy, product strategy, and market strategy (Clark and 
Wheelwright 1993).  
To measure a company’s NPD portfolio the respondent was asked to indicate the percentage 
radical, incremental and next generation projects in the portfolio (Wheelwright and Clark 1992). 
The percentages had to sum up to 100%. 
 10 
Data Analysis Techniques 
For analysis of the data we first rely on a theoretical proposition (Yin 1994). We are interested in a) 
the variance of both the product concept effectiveness and the development process effectiveness, 
and b) the organization of the NPD function that the companies in our dataset possibly share. The 
variances are calculated in the statistics program SPSS. We conducted a structured survey in 11 
SMEs in the medical devices sector. In line with the methodological suggestions of Eisenhardt 
(1989) we made case summaries and analyzed each case individually. In addition to the structured 
survey, we conducted 2 in-depth case studies: one in the highest performing company, and one in 
the one but lowest performing company of our dataset. These case studies 1) show if there is single 
respondent bias or not (see next paragraph) and 2) give background information and enlighten the 
results we found with the structured survey.  
 
Single respondent bias 
One of the problems of response in survey research is single respondent bias. We compensated this 
by controlling for single respondent bias. From our dataset of 11 companies we selected two com-
panies for case studies on the climate variable. The companies were selected on their scores on de-
velopment process effectiveness and current NPD performance (highest scoring company and low-
est scoring company). Besides the full questionnaire that was filled in by the NPD manager, at least 
5 employees in both companies filled in a minisurvey that was solely focused on the NPD climate. In 
this way we could compare the filled in answers of the NPD manager to those of different employ-
ees in the company. For both cases we found no significant difference (Sign. p> 0,00 for both cases) 
between the answers of the NPD manager who filled in the full questionnaire and the answers that 
were given by the employees in the minisurveys (see Table 4). This excludes single respondent 
bias. 
 
Table 4: Single respondent bias results 
 
Results 
We have presented two propositions which we tested. Our first proposition was that SMEs in the 
medical devices sector focus on their development process effectiveness rather than on their prod-
uct concept effectiveness to achieve high NPD performance. Table 5 shows the results of the vari-
ance in both the product concept effectiveness and the development process effectiveness.  
 
 
 
 
 
Test Statistics Casestudy 1 b 
-,178 a 
,859 
Z 
Asymp. Sig. (2-tailed) 
NPDmanager_1 
 
Minisurvey_1 
Based on positive ranks. a. 
Wilcoxon Signed Ranks Test b. 
Test Statistics Casestudy 2 b 
-1,244 a 
,214 
Z 
Asymp. Sig. (2-tailed) 
NPDmanager_2 
 
Minisurvey_2 
Based on positive ranks. a. 
Wilcoxon Signed Ranks Test b. 
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Table 5: Variances in product concept effectiveness (PCE) and development process effectiveness 
(NPDpe) 
 
 N Mean Std. Deviation Variance 
PCE 11 5,1523 ,78841 ,622 
NPDpe_real 11 4,4693 ,95286 ,908 
Valid N (listwise) 11    
 
 
We calculated the variances in both concepts to see whether the scores of the product concept 
effectiveness indeed vary less, or are more stable, than the scores of the development process effec-
tiveness. When the variance of the product concept effectiveness between the companies is low, the 
product concept effectiveness is not the construct that makes it possible for companies to distin-
guish themselves in terms of current NPD performance. Instead, the development process effec-
tiveness is what distinguished companies in terms of current NPD performance. It becomes appar-
ent from Table 5 that 1) the variance of the product concept effectiveness is low and 2) the variance 
of the development process effectiveness is high (see Table 5). This indicates that the development 
process effectiveness is indeed the variable that distinguishes between the NPD performances of 
SMEs.  
 
Our second proposition was that SMEs in the medical devices sector that achieve high develop-
ment process effectiveness share a pattern in the organization of their NPD function. We divided 
the dataset in high and low performing companies based on the standards described and shown in 
Table 3 in the measurements section. The case summaries in Table 6 show the organizational pat-
terns of the NPD functions amongst the high performers and amongst the low performers. 
 
Table 6: Case summaries of the internal organization of the companies in the dataset 
Development 
process ef-
fectiveness 
Case# Portfolio 
Team_ 
Structure 
Formalization Climate 
Low 
 
 
 
1 
Main focus on 
radical innova-
tion 
Heavyweight 
Team Structure 
no formalized 
process 
no innova-
tive climate 
5 
Main focus on 
incremental 
innovation 
Heavyweight 
Team Structure 
no formalized 
process 
no innova-
tive climate 
2 
Main focus on 
radical innova-
tion 
Heavyweight 
Team Structure 
formalized 
process 
innovative 
climate 
3 
Main focus on 
radical innova-
tion 
Functional 
Team Structure 
no formalized 
process 
no innova-
tive climate 
High 
 
 
 
 
 
 
6 
Main focus on 
radical innova-
tion 
Heavyweight 
Team Structure 
no formalized 
process 
innovative 
climate 
11 
Main focus on 
incremental 
innovation 
Functional 
Team Structure 
no formalized 
process 
innovative 
climate 
4 
Main focus on 
incremental 
innovation 
Functional 
Team Structure 
no formalized 
process 
innovative 
climate 
 12 
9 
Main focus on 
incremental 
innovation 
Functional 
Team Structure 
no formalized 
process 
no innova-
tive climate 
8 
Main focus on 
incremental 
innovation 
Heavyweight 
Team Structure 
no formalized 
process 
innovative 
climate 
7 
Main focus on 
radical innova-
tion 
Autonomous 
Team Structure 
formalized 
process 
no innova-
tive climate 
10 
Main focus on 
incremental 
innovation 
Functional 
Team Structure 
no formalized 
process 
no innova-
tive climate 
Total N 11     
 
At first glance, the case summaries in Table 6 show a lot of variety in the organization of the NPD 
function. However, when taking a closer look, a number of patterns in the organization of the NPD 
function become apparent.  
 
NPD Strategy 
A first pattern can be found in the project portfolio of the companies. The high performing compa-
nies focus in general on incremental innovation projects, whereas the low performing companies 
focus more on radical innovation projects. This might be explained by the highly regulated sectors 
in which these companies operate. The new developed products must meet fixed standards which 
leaves little room for radical innovations. It is safer to focus on incremental innovation projects, 
since these types of projects can easier meet regulations than radical innovation projects. 
 
NPD Structure 
The second pattern is found in the link between team structure and portfolio. The high performing 
companies 4, 9, 10 and 11 combine an incremental project portfolio with a functional team struc-
ture. These findings suggest that the combination of an incremental project portfolio with a func-
tional team structure leads to high development process effectiveness. This is also in line with the 
research of De Visser et al (2009) who find that “firms that manage to apply a cross-functional inte-
gration structure for their radical NPD processes and a functional integration structure for their 
incremental NPD processes will be the most successful in terms of balancing derivative and break-
through innovation performance” (De Visser et al. 2009).  
Furthermore our findings suggest that the combination of a radical project portfolio with a 
heavyweight or autonomous team structure (as seen in case companies 6 and 7) can also lead to 
high development process effectiveness, when combined with an informal NPD process and innova-
tive climate, or with a formal NPD process and climate that is not innovative. 
 
NPD climate and NPD process 
From the (low performing) case companies 1, 3, and 5 in our dataset, it seems that lacking both a 
formalized NPD process and an innovative NPD climate doesn’t lead to high development process 
effectiveness, unless combined with a functional team structure like in the high performing case 
companies 9 and 10. In these two latter cases, the functional team structure compensates the lack 
of formalization to some extent. Also having both a formalized NPD process and innovative NPD 
climate, like in case company 2, doesn’t lead to high development process effectiveness. Combining 
a formalized NPD process with a NPD climate that isn’t innovative and vice versa, seems to lead to 
high development process effectiveness. This can be seen in the high performing case companies 4, 
6, 7, 8 and 11 and is the third pattern we find. 
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The above results show that, companies in the Spanish medical devices sector indeed share a pat-
tern in their NPD function. This supports our second proposition. To summarize, we found a num-
ber of patterns in the organization of the NPD function of high vs. low performing companies. 
First of all, indeed the companies in the dataset which focused on the effectiveness of their devel-
opment process, stood out in NPD performance. Further, the higher performing companies did have 
a number of commonalities in the organisation of their NPD function:   
1) The majority of the higher performing firms had an NPD strategy characterized by a predomi-
nantly incremental project portfolio. 
2) a) Successful firms with an incremental project portfolio combined this with a functional team 
structure  
b) Successful firms with a radical project portfolio combined this with a heavyweight or auto-
nomous team structure. 
3) A negative reciprocal relationship exists between formalization of the NPD processes and the 
climate of the NPD function, in that a formalized NPD process and an innovative climate do not 
seem to reinforce each other. Innovative climate combined with an informal NPD process does 
however contribute positively to NPD performance. This effect was stronger in combination 
with a radical project portfolio. 
 
What the above summarized research results mean in everyday business practice is illustrated in 
the following two cases. Both companies are part of our dataset of Spanish medical devices compa-
nies. Company 5 (Text Box 1) is the last but one lowest performing company, Company 10 (Text 
Box 2) is the highest performing company. 
 
Text Box 1: Case illustration company 5 
 
The level of risk taking in company 5 is low and, as described in text box 1, the focus is on incre-
mental new products (in line with pattern 1). The focus on incremental innovation projects is com-
bined with a heavyweight team structure in which project teams are to a large extent autonomous 
and project team leaders have the authority to decide about the division of the budget and people 
within the project. This type of team structure is more applicable to radical innovation projects, 
since these projects need more freedom to think “outside-the-box”, without being constrained by 
everyday company boundaries. In incremental innovation projects this heavyweight team structure 
CASE COMPANY 5: A LOW PERFORMER 
 
Company 5 is a low performing company that focuses on the development, production, and com-
mercialization of prostheses and implants. They want to offer a complete range of products to 
their clients (surgeons) even though a number of these products are not profitable. In addition, 
time is not regarded the most important. Over the years, the company has focused more and more 
on R&D, and they also work on their image of an innovative company. The role of senior man-
agement in this is to set an example to the employees and improve the work where possible. 
However, employees are not stimulated nor compensated to come up with new ideas or new de-
velopments. When employees come up with new ideas, the management listens to the ideas of the 
employees and approves or disapproves and gives advice about other possibilities. Most of the 
time these new ideas are shared only among fellow employees, as employees are not stimulated 
(nor compensated) to come up with innovative ideas or new developments. Conflicts between 
R&D and commercial functions arise when a time plan and quality are promised to customers 
which are not feasible in practice. Risk taking in new product development by the employees and 
the management is low. 
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is often too heavy in that in incremental innovation projects the project team should remain close 
to everyday company business, without getting carried away. A functional team structure is in the 
case of incremental innovation better applicable. However company 5 combines a focus on incre-
mental innovation with a heavyweight team structure (conflicts with pattern 2). From text box 1 it 
becomes clear, that the climate in company 5 is not innovative, since employees are not stimulated 
nor compensated to come up with new ideas or new developments. Management decides about 
new product development projects, which are executed in a development process that isn’t formal-
ized. This combination of a process that isn’t formalized and a climate that isn’t innovative conflicts 
with pattern 3. 
Only pattern 1, a focus on incremental innovation projects, can be found in company 5. Neither 
pattern 2 (the presence of a functional team structure in combination with an incremental product 
portfolio), nor pattern 3 (the reciprocal relationship between formalization of the NPD process and 
the climate of the NPD function) are present in company 5. The fact that the majority of the organ-
izational patterns that were found to positively contribute to NPD performance miss in company 5 
might explain its low NPD performance. 
 
Text Box 2: Case illustration company 10 
 
Case company 10 clearly focuses on incremental innovation projects (in line with pattern 1). Text 
box 2 explains that company 10 wants to exploit their current market further and new product de-
velopment projects should fit with current technologies and products. This focus on incremental 
product development projects is combined with a functional team structure (in line with pattern 2) 
in which management coordinates all the work. The climate is more innovative than in case compa-
ny 5, because employees in company 10 have room to discuss their ideas in organized informal 
product meetings (see text box 2). However the climate in company 10 is not that innovative since 
only incrementally new ideas are appreciated and final decisions are all made top-down. The go/ no 
go decision about the development project is formal. However, the development process itself is not 
formalized. The combination of a development process that is not formalized with a climate that is 
not innovative is compensated in company 10 through the functional team structure (in line with 
pattern 3). 
The organizational patterns 1, 2, and 3 that were found to contribute positively to NPD perfor-
mance are all present in case company 10. The fact that all three patterns are present in company 
CASE COMPANY 10: A HIGH PERFORMER 
 
Our second case company, company 10, is a high performing company that focuses on dental 
equipment and optical units. They offer solutions to other companies (they work for) and in-
crease patient comfort with their products. They want to concentrate on further exploitation of 
the markets they currently serve, instead of focussing on radically new products. They want to 
grow, but also stay a medium-sized company. It should be a controlled increase. Part of the prod-
ucts are developed for other companies and part of the products are developed for the market. 
Meeting the – tight - time schedules is of highest importance. The senior management coordinates 
all the work and ideas in a functional team structure. Every three months product meetings are 
organized in which from every department people from the work floor are present. In these meet-
ings ideas are shared with the management, and are selected. The selected ideas are tested by the 
technical department and if the idea fits within the current technologies and products it will be 
further explored. However, the final decisions are made top-down. Risk taking is only accepted if 
it is in line with current technologies and products. 
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10, and the fact that the majority of these patterns is missing in company 5 might explain the differ-
ence in NPD performance between both companies. 
 
Discussion 
Our findings raise some questions about the organization of new product development in highly 
regulated sectors. We find that companies in the highly regulated medical devices sector should 
focus on incremental innovation projects for high current NPD performance. Does this mean that 
these companies have to neglect radical innovation projects? The fact that our research findings 
state that a majority of incremental projects should be present can be explained by our focus on 
current NPD performance, which reflects the NPD performance on the short term. To be able to also 
achieve high future (long-term) NPD performance a company should not only be operational effec-
tive, but also strategically flexible (DeWeerd-Nederhof et al. 2008). To achieve high future NPD per-
formance the project portfolio should also contain projects that gain future revenues even though 
they aren’t profitable at first glance. This is often the case with radical innovation projects. We ex-
pect that when the focus is on future NPD performance, radical innovation projects should be more 
dominantly present in the project portfolio. When the focus shifts from current to future NPD per-
formance we expect that the organization of the NPD function shifts from an operational effective 
organization with a focus on incremental innovation projects, to a strategically flexible organization 
with a focus on radical innovation projects. 
With regard to the formalization of the NPD process and innovativeness of the NPD climate, we 
found a negative reciprocal relationship, in that a formalized NPD process and an innovative cli-
mate do not seem to reinforce each other. Innovative climate combined with an informal NPD 
process does however contribute positively to NPD performance. These findings conflict with 
theory. On the one hand, theory stated that a climate that stimulates innovation is a climate with 
high levels of “challenge, freedom, idea support, trust, playfulness, debates, risk taking, and idea 
time” (Ekvall 1996). On the other hand, theory states that, companies with a formal development 
process are more successful in the commercialization of new products (Booz and Hamilton 1982). 
Now, is theory wrong, or not applicable? Theory is not wrong and is also applicable, but the theo-
retical approach towards these variables should be more subtle. Companies do not consist of only 
one variable or characteristic, but of a multitude of variables and characteristics that are all interre-
lated.  
Finally, we focused on a highly regulated sector and found that companies in this sector can only 
compete on development process effectiveness. This is caused by the fact that the product concept 
effectiveness is to a great extent predetermined by the set regulations. The product concept effec-
tiveness of companies in sectors that are not highly regulated is not predetermined, which means 
that companies in non-regulated sectors have not only the possibility to compete on development 
process effectiveness, but also on product concept effectiveness. Then, to what extent do our re-
search findings also apply in non-regulated sectors?  
The short-term/ long-term effects of the project portfolio on the NPD performance also apply in 
non-regulated sectors. Incremental innovation projects lead to higher revenues on the short term, 
whereas radical innovation projects lead to higher revenues on the long term. The other patterns 
we found (pattern nr. 2 and 3) are strongly related to the achievement of high development process 
effectiveness. We expect that these patterns also apply in non-regulated sectors. However only in-
creasing the development process effectiveness in companies in non-regulated sectors has proba-
bly less effect on the NPD performance as increasing the development process effectiveness in 
highly regulated companies. In non-regulated sectors, also the differences in product concept effec-
tiveness are heavily influencing the NPD performance and need to be taken into account. 
 
Conclusions 
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The contribution of the research outlined above is that it shows SMEs in regulated sectors how 
competitive advantage in terms of NPD performance could be achieved, namely by optimizing their 
development process effectiveness and by choosing an appropriate organization of the NPD func-
tion. The research explicitly focused on the combination of organisational variables instead of fo-
cusing only on one variable, which adds value to other scholarly work on the same topic. 
In line with our theoretical proposition, we find that small- and medium sized companies in the 
Spanish medical devices sector can indeed improve the performance of their NPD function by fo-
cusing on the speed, flexibility, and productivity of their NPD function. Furthermore we find that, 
companies with high current NPD performance in terms of development process effectiveness have 
a number of commonalities in the organization of their NPD function. These companies either com-
bine an incremental project portfolio with a functional team structure, or they combine a radical 
project portfolio with a heavyweight or autonomous team structure. It should be noted that most of 
the firms with high development process effectiveness empoyed an NPD strategy focusing on in-
cremental innovation. Further, a reciprocal relationship between formalization of the NPD 
processes and the climate of the NPD function was found, in that a formalized NPD process and an 
innovative climate do not seem to reinforce each other. Innovative climate combined with an in-
formal NPD process does however contribute positively to NPD performance, especially for the mi-
nority of firms in the set with an NPD strategy focusing more on radical innovation. . 
It should be noted however, that as was explained in the theoretical framework section, the NPD 
performance is a dynamic concept that has both a short-term (Operational Effectiveness) and a 
long-term (Strategic Flexibility) component. For this research the focus is on operational effective-
ness as the aim is to measure the current NPD performance. Although the results of our study might 
lead one to believe that in highly regulated sectors the only way to innovate is in incremental steps , 
this is somewhat misleading because of the short term –operational effectiveness view employed in 
the research. For radical innovation to lead to competitive advantage indeed also some organiza-
tional characteristics have been found, but the beneficial effect on both development process and 
product concept effectiveness might be subject to considerable time delay, especially in the medical 
devices sector.  
 
For further research we strive to conduct longitudinal research in this field. The data of this re-
search was gathered at one point in time, but since new product development is dynamic, longitu-
dinal research might be interesting. Furthermore, it could be worthwhile to test our research find-
ings in other countries and other strictly regulated sectors. We specifically looked at the context of 
the Spanish medical devices sector, but since the strict regulations for new medical devices are 
comparable in most countries, our findings might be applicable in other countries. Also, there are a 
number of other sectors that have similar characteristics in terms of regulations. Although further 
research is needed, we expect to find a similar pattern in the internal organization of the NPD func-
tion of successful companies in other highly regulated sectors for a larger dataset. Suggestions for 
other sectors are the biotechnology (Senker 1991) and commercial space sector (Carayannis and 
Samanta Roy 2000).  
 
Managerial Implications 
So, what do the research findings mean in everyday business practice? It not possible to give a full 
recipe for successful new product development, but we can demonstrate the value of certain ingre-
dients, and, just as importantly, warn for the excessive use of some other ingredients.  There are 
several myths about the organization of new product development that are among CTO’s and man-
agers of new product development. In this research we tackled four of these myths. 
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Myth 1: First focus on the quality, safety, and manufacturability of the product, then take a look at 
your NPD process. 
We have shown that, in a regulated sector, the quality, safety, and manufacturability standards are 
predetermined through regulations. High quality, safety, and manufacturability of products are a 
precondition, regardless of the company, and not leading to competitive advantage. As a manager, 
you should focus on your NPD process. The development speed should be high (don’t waste time), 
the development process should be flexible (be able to change fast if specifications change), and the 
development process should have high productivity (don’t exceed costs nor budgeted hours). 
 
Myth 2: The more innovative, the better. 
Managers are often confronted with the idea that radical innovation is just it. We have shown that 
taking little steps in the innovativeness of new products is – at least in regulated sectors - more suc-
cessful. Managers should take a look at the portfolio of different innovation projects in their com-
panies. How is the balance between incremental and radical innovation projects? If the portfolio 
mainly contains radical innovation projects and lacks incremental innovation projects, they should 
try to shift this balance by attracting more incremental innovation projects. However, keep in mind 
that the pursuit of radical innovations should not be fully abandoned, since they are needed for fu-
ture profits. 
 
Myth 3: Project teams should be autonomous and not restricted by organizational procedures. 
There is not one best way to structure your NPD teams. The best way to organize projects heavily 
depends on the type of development projects. As a manager you should take a look at your project 
portfolio and at the team structure you use. In an incremental project portfolio, the projects are not 
so new and unknown that you need self-steering project teams. Rather, project teams are required 
that remain close to the company and do not get carried away. For incremental innovation, you 
should create project teams in which members remain on their current locations, in which different 
functions coordinate ideas through detailed specifications, in which occasional meetings are organ-
ized to discuss issues that cut across groups, and in which the responsibility passes sequentially 
from one function to the next. The more radically new the project is, the more the final project re-
sponsibility shifts towards the project leader and the more responsibilities the project team should 
get in general. 
 
Myth 4: The NPD climate should be innovative and the NPD process should be formal. 
We have shown that the innovativeness of the climate and the formalization of the NPD process do 
not reinforce each other. It is either-or, not both. This means that, there are two roads to success: 
you, as a manager, either work on an innovative climate, or you work on an well formalised NPD 
process. Considering the NPD climate, questions you need to pose to yourself are: how much time, 
freedom, support, and trust do employees get to develop new ideas? Are employees challenged? 
Are employees allowed to take risks? If you answer most of these questions positively, the climate 
in your NPD function can be considered innovative. If you answer most of these questions nega-
tively, you haven’t got an innovative climate. Considering the formalization of the NPD process ask 
yourself if your organization follows a formally documented NPD process or not. For high current 
NPD performance either an innovative climate or a formalised process should be present. 
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